Related Experiment Video
Updated: Jun 21, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
[Affection of target organs in hypertensive patients with and without metabolic syndrome]
Insights
Metabolic syndrome accelerates target organ damage in patients with arterial hypertension (AH). This study found that metabolic syndrome leads to earlier and more severe heart, kidney, and vessel damage in AH patients.
Area of Science:
- Cardiology
- Nephrology
- Vascular Medicine
Background:
- Arterial hypertension (AH) is a significant risk factor for cardiovascular and renal diseases.
- Metabolic syndrome (MS) is increasingly recognized as a contributor to cardiovascular complications.
- Understanding the interplay between AH, MS, and target organ damage is crucial for effective management.
Purpose of the Study:
- To investigate the impact of metabolic syndrome (MS) on target organ damage in patients with arterial hypertension (AH).
- To compare the severity of cardiac, renal, and vascular damage in hypertensive patients with and without MS.
- To assess the correlation between metabolic abnormalities and specific markers of organ damage.
Main Methods:
- Enrolled 303 patients with AH (grades 1-3), divided into groups with and without MS.
- Assessed lipid profile, blood glucose, glomerular filtration rate, and microalbuminuria (MAU).
- Utilized 24-hour blood pressure monitoring, echocardiography, and carotid artery Doppler ultrasonography.
Main Results:
- Early AH showed diastolic left ventricular (LV) dysfunction, reduced glomerular filtration rate, and MAU.
- AH grade 2 was associated with LV remodeling; grade 3 showed increased LV myocardial mass (LVMM) and intima-media thickness (TIM).
- Strong correlations were observed between diastolic dysfunction, MAU, LVMM, and TIM.
Conclusions:
- Metabolic syndrome exacerbates target organ damage in arterial hypertension.
- Hypertensive patients with MS experience earlier and more severe cardiac, renal, and vascular alterations.
- Early detection and management of MS are vital in AH patients to prevent progressive organ damage.
Aim:
To study damage to the heart, kidneys and vessels in patients with arterial hypertension (AH) of different severity with and without metabolic syndrome.
Material And Methods:
The trial enrolled 303 patients with AH of the first-third degree aged 25-70 years (mean age 52 +/- 18 years), 110 males and 193 females. The patients were matched by sex and age. All the patients were divided into two groups: group 1 (n = 151) without metabolic syndrome (MS) and group 2 (n = 152) with MS. The following parameters were studied: lipid spectrum, blood glucose, glomerular filtration rate, MAU, data of 24-h blood pressure monitoring, echocardiography, Doppler ultrasonography of the brachiocephalic arteries.
Results:
Early AH was accompanied with diastolic LV myocardial dysfunction, subnormal glomerular filtration rate and the presence of MAU. In AH of the second degree there was LV remodeling. In AH of the third degree left ventricular myocardial mass (LVMM) and thickness of intima-medial complex (TIM) were increased. Close correlations were found between the disturbance of diastolic function and MAU, thickness of interventricular septum and thickness of the inferior wall and LVMM index with MAU. Less manifest correlation existed between diastolic dysfunction and TIM, thickness of the interventricular septum and thickness of the inferior wall and TIM.
Conclusion:
The presence of metabolic syndrome contributes to earlier and more serious damage of the target organs in patients with arterial hypertension.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Heart Failure II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
